MYC and cancer: In cancer, polyamine metabolism is frequently dysregulated, and multiple oncogenic pathways could result in upregulated polyamine synthesis, such as MYC, RAS-RAF-MEK-ERK, and PTEN-PI3K-mTORC1 signalling.